Innospec Inc. (NASDAQ:IOSP) Shares Acquired by New York State Teachers Retirement System

New York State Teachers Retirement System grew its holdings in Innospec Inc. (NASDAQ:IOSPFree Report) by 16.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,110 shares of the specialty chemicals company’s stock after purchasing an additional 2,185 shares during the period. New York State Teachers Retirement System’s holdings in Innospec were worth $1,862,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Sei Investments Co. lifted its stake in shares of Innospec by 8.7% in the 3rd quarter. Sei Investments Co. now owns 128,506 shares of the specialty chemicals company’s stock valued at $13,133,000 after purchasing an additional 10,268 shares during the last quarter. AMG National Trust Bank acquired a new position in Innospec during the 3rd quarter worth about $907,000. Assenagon Asset Management S.A. acquired a new position in Innospec during the 3rd quarter worth about $1,207,000. Charles Schwab Investment Management Inc. lifted its stake in Innospec by 4.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 298,635 shares of the specialty chemicals company’s stock worth $30,520,000 after acquiring an additional 12,135 shares in the last quarter. Finally, Diversified Trust Co lifted its stake in Innospec by 1.7% during the 4th quarter. Diversified Trust Co now owns 11,154 shares of the specialty chemicals company’s stock worth $1,375,000 after acquiring an additional 185 shares in the last quarter. Institutional investors and hedge funds own 96.64% of the company’s stock.

Innospec Trading Down 0.7 %

IOSP opened at $120.97 on Wednesday. The stock’s 50-day moving average price is $124.08 and its 200 day moving average price is $114.96. Innospec Inc. has a 12-month low of $91.74 and a 12-month high of $131.18. The firm has a market cap of $3.02 billion, a price-to-earnings ratio of 21.72 and a beta of 1.10.

Innospec (NASDAQ:IOSPGet Free Report) last posted its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.59 by $0.25. Innospec had a return on equity of 13.69% and a net margin of 7.14%. The firm had revenue of $494.70 million for the quarter, compared to analyst estimates of $479.47 million. During the same quarter in the prior year, the company earned $1.20 EPS. Innospec’s revenue was down 3.1% on a year-over-year basis. On average, research analysts forecast that Innospec Inc. will post 6.72 earnings per share for the current year.

Insiders Place Their Bets

In other Innospec news, SVP David B. Jones sold 2,500 shares of the company’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $125.79, for a total transaction of $314,475.00. Following the sale, the senior vice president now owns 9,664 shares in the company, valued at approximately $1,215,634.56. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other Innospec news, CEO Patrick Williams sold 9,667 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $124.37, for a total transaction of $1,202,284.79. Following the sale, the chief executive officer now owns 174,334 shares in the company, valued at approximately $21,681,919.58. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP David B. Jones sold 2,500 shares of the company’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $125.79, for a total value of $314,475.00. Following the sale, the senior vice president now owns 9,664 shares in the company, valued at approximately $1,215,634.56. The disclosure for this sale can be found here. Insiders have sold a total of 36,500 shares of company stock worth $4,532,959 in the last quarter. 1.35% of the stock is owned by company insiders.

Innospec Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

See Also

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.